Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice
- PMID: 20883320
- DOI: 10.1111/j.1365-3083.2010.02448.x
Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice
Abstract
The currently used vaccine against tuberculosis, Bacille Calmette-Guérin (BCG), has variable efficacy, so new vaccine development is crucial. In this study, we evaluated a recombinant vaccine prepared from non-pathogenic Mycobacterium smegmatis (rMS) that expresses a fusion of early secreted antigenic target 6-kDa antigen (ESAT6) and culture filtrate protein 10 (CFP10). C57BL/6 mice were immunized with the rMS expressing the ESAT6-CFP10 fusion protein (rM.S-e6c10) or with BCG. The mice in the rM.S-e6c10 group had a significantly higher titre of anti-ESAT6-CFP10 antibodies than did animals in the BCG or saline groups. Spleen cells from rM.S-e6c10-immunized mice exhibited a cytotoxic response to ESAT6 and CFP10-expressed target cells, but spleen cells from animals in the other groups did not. Levels of IFN-γ and IL-2 production by purified T cells from spleens were significantly higher in rM.S-e6c10 group than in BCG group. Finally, after M. tuberculosis (MTB)-challenged mice, dramatic reduction in the numbers of MTB colony-forming units (CFUs) in the lungs was observed for the mice immunized with the rMS. The protective efficacy of rM.S-e6c10 and BCG vaccination was similar based on measures of MTB burden and lung pathology. Our data indicate that the recombinant M. smegmatis vaccine expressing the ESAT6-CFP10 fusion protein has potential in clinic application.
© 2010 The Authors. Scandinavian Journal of Immunology © 2010 Blackwell Publishing Ltd.
Similar articles
-
[Immune response and protective efficacy induced by fusion protein ESAT6-CFP10 of M.tuberculosis in mice].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 Jul;22(4):443-6. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006. PMID: 16806004 Chinese.
-
[Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Mar;25(3):211-4. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009. PMID: 19257983 Chinese.
-
[Immunity characteristics induced by a genetic vaccine expressing Ag85B-ESAT6 fusion protein].Zhonghua Jie He He Hu Xi Za Zhi. 2005 Nov;28(11):777-80. Zhonghua Jie He He Hu Xi Za Zhi. 2005. PMID: 16324275 Chinese.
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
-
Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.Vaccine. 2014 Feb 3;32(6):712-6. doi: 10.1016/j.vaccine.2013.11.065. Epub 2013 Dec 2. Vaccine. 2014. PMID: 24300592 Review.
Cited by
-
Comparative evaluation of MPT83 (Rv2873) for T helper-1 cell reactivity and identification of HLA-promiscuous peptides in Mycobacterium bovis BCG-vaccinated healthy subjects.Clin Vaccine Immunol. 2011 Oct;18(10):1752-9. doi: 10.1128/CVI.05260-11. Epub 2011 Aug 18. Clin Vaccine Immunol. 2011. PMID: 21852544 Free PMC article.
-
Mycobacterium smegmatis, a Promising Vaccine Vector for Preventing TB and Other Diseases: Vaccinomics Insights and Applications.Vaccines (Basel). 2023 Jul 31;11(8):1302. doi: 10.3390/vaccines11081302. Vaccines (Basel). 2023. PMID: 37631870 Free PMC article. Review.
-
Evaluating the Performance of PPE44, HSPX, ESAT-6 and CFP-10 Factors in Tuberculosis Subunit Vaccines.Curr Microbiol. 2022 Jul 19;79(9):260. doi: 10.1007/s00284-022-02949-8. Curr Microbiol. 2022. PMID: 35852636 Free PMC article. Review.
-
The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins.PLoS One. 2020 Feb 6;15(2):e0228381. doi: 10.1371/journal.pone.0228381. eCollection 2020. PLoS One. 2020. PMID: 32027660 Free PMC article.
-
Oral immunization with recombinant Mycobacterium smegmatis expressing the outer membrane protein 26-kilodalton antigen confers prophylactic protection against Helicobacter pylori infection.Clin Vaccine Immunol. 2011 Nov;18(11):1957-61. doi: 10.1128/CVI.05306-11. Epub 2011 Sep 7. Clin Vaccine Immunol. 2011. PMID: 21900527 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources